Literature DB >> 7072022

DNA profile and tumour progression in patients with superficial bladder tumours.

H Gustafson, B Tribukait, P L Esposti.   

Abstract

229 patients with Grade 1-2 tumours (WHO), all category Ta or T1 (UICC) and surgically treated, were followed clinically and by flowcytofluorometric DNA-analysis (FCM). The tumours were characterised by their DNA profile. 175 cases were found to be diploid and fifty-four cases showed aneuploidy. The mean follow-up time with continuous FCM analysis was 2.6 years. During this period 19 patients showed tumour progression and 11 of these patients died. No progressive cases were found among 175 patients with repeatedly diploid DNA patterns. Thus tumour progression was exclusively linked to an aneuploid DNA pattern. In these case the degree of ploidy determined the frequency of progression: while 50% of the cases with triploid--hypotetraploid DNA pattern showed progression, only 10% of tumours with a tetraploid amount of DNA were found to be progressive. The degree of ploidy in 33 cases with recurrent aneuploid tumours was in general found to be constant. A fairly high degree of consistency was also found in the number of cells in S-phase, expressing proliferative properties. This indicates that superficial bladder tumours can be well characterised by their DNA profiles, that is the degree of ploidy and the proliferation pattern.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7072022     DOI: 10.1007/bf00256518

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  8 in total

1.  Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years.

Authors:  A Bergkvist; A Ljungqvist; G Moberger
Journal:  Acta Chir Scand       Date:  1965-10

2.  The clinical and histopathological significance of Feulgen DNA-values in transitional cell carcinoma of the human urinary bladder.

Authors:  S D Fossa; O Kaalhus; O Scott-Knudsen
Journal:  Eur J Cancer       Date:  1977-10       Impact factor: 9.162

3.  Quantitative flow-microfluorometric analysis of the DNA in cells from neoplasms of the urinary bladder: correlation of aneuploidy with histological grading and the cytological findings.

Authors:  B Tribukait; P L Esposti
Journal:  Urol Res       Date:  1978

4.  Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ.

Authors:  A F Althausen; G R Prout; J J Daly
Journal:  J Urol       Date:  1976-11       Impact factor: 7.450

5.  The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases.

Authors:  B Tribukait; H Gustafson; P L Esposti
Journal:  Br J Urol       Date:  1982-04

6.  Ploidy and proliferation in human bladder tumors as measured by flow-cytofluorometric DNA-analysis and its relations to histopathology and cytology.

Authors:  B Tribukait; H Gustafson; P Esposti
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

7.  [Impulse cytophotometric studies on DNA in bladder carcinoma].

Authors:  B Tribukait; H Gustafson
Journal:  Onkologie       Date:  1980-12

8.  Tumour ploidy and prognosis in carcinomas of the bladder and prostate.

Authors:  A S Tavares; J Costa; A de Carvalho; M Reis
Journal:  Br J Cancer       Date:  1966-09       Impact factor: 7.640

  8 in total
  16 in total

1.  Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.

Authors:  C E Blomjous; N W Schipper; J P Baak; E M van Galen; H J de Voogt; C J Meyer
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

2.  Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables.

Authors:  P S Rabinovitch; G Longton; P L Blount; D S Levine; B J Reid
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

3.  Clinical DNA flow cytometry.

Authors:  B Tribukait
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

4.  Fluorescence methods for measuring the A, B, and H isoantigens on cytological material from bladder carcinoma.

Authors:  E Borgström; B Wahren; H Gustafson
Journal:  Urol Res       Date:  1985

Review 5.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

6.  Proliferative pattern of urothelial bladder cancer and urothelial atypias.

Authors:  B Helpap; H W Schwabe; H D Adolphs
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

7.  Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocol.

Authors:  T Bösing; A Roessner; W Hiddemann; W Mellin; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 8.  Karyotypic progression in human tumors.

Authors:  S R Wolman
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

9.  Flow-cytophotometric studies in renal carcinoma.

Authors:  H W Schwabe; H D Adolphs; J Vogel
Journal:  Urol Res       Date:  1983

10.  Flow-cytophotometric studies on urine sediments of patients treated with anti-cancer-drugs.

Authors:  H W Schwabe; H D Adolphs; J Hartlapp
Journal:  Urol Res       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.